Journal
CARDIOLOGY
Volume 113, Issue 3, Pages 155-160Publisher
KARGER
DOI: 10.1159/000187652
Keywords
Cell therapy; Neovascularization; Stem cells; Acute myocardial infarction
Categories
Ask authors/readers for more resources
Cell-based therapy is a promising option for treatment of cardiovascular diseases. Based on experimental studies demonstrating that bone marrow-derived stem and progenitor cells improve the functional recovery after ischemia, clinical trials were initiated to address this new therapeutic concept. So far, clinical studies preferentially used adult bone marrow-derived cells for the treatment of patients with acute myocardial infarction. Overall, cell therapy was shown to reduce the infarct size and improve cardiac contractile function. However, the extent of functional improvement varied between the studies and various questions remain. The present review article will discuss the heterogeneity of the clinical results, the timing of the cell delivery and the benefit achieved so far in different patient populations. Copyright (C) 2008 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available